Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Jan. 19, 2024
Diabetic
kidney
disease
(DKD)
stands
as
the
predominant
cause
of
chronic
(CKD)
on
a
global
scale,
with
its
incidence
witnessing
consistent
annual
rise,
thereby
imposing
substantial
burden
public
health.
The
pathogenesis
DKD
is
primarily
rooted
in
metabolic
disorders
and
inflammation.
Recent
years
have
seen
surge
studies
highlighting
regulatory
impact
energy
metabolism
innate
immunity,
forging
significant
area
research
interest.
Within
this
context,
fibroblast
growth
factor
21
(FGF21),
recognized
an
regulator,
assumes
pivotal
role.
Beyond
role
maintaining
glucose
lipid
homeostasis,
FGF21
exerts
influence
concurrently
inhibiting
inflammation
fibrosis.
Serving
nexus
between
has
evolved
into
therapeutic
target
for
diabetes,
nonalcoholic
steatohepatitis,
cardiovascular
diseases.
While
relationship
garnered
increased
attention
recent
studies,
comprehensive
exploration
association
yet
to
be
systematically
addressed.
This
paper
seeks
fill
gap
by
summarizing
mechanisms
through
which
operates
DKD,
encompassing
facets
immunity.
Additionally,
we
aim
assess
diagnostic
prognostic
value
explore
potential
treatment
modality
condition.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(15), P. 12378 - 12378
Published: Aug. 3, 2023
Diabetes
mellitus
(DM)
belongs
to
the
category
of
socially
significant
diseases
with
epidemic
rates
increases
in
prevalence.
Diabetic
nephropathy
(DN)
is
a
specific
kind
kidney
damage
that
occurs
40%
patients
DM
and
considered
serious
complication
DM.
Most
modern
methods
for
treatments
aimed
at
slowing
down
progression
DN
have
side
effects
do
not
produce
unambiguous
positive
results
long
term.
This
fact
has
encouraged
researchers
search
additional
or
alternative
treatment
methods.
Hyperglycemia
negative
effect
on
renal
structures
due
number
factors,
including
activation
polyol
hexosamine
glucose
metabolism
pathways,
renin-angiotensin-aldosterone
sympathetic
nervous
systems,
accumulation
advanced
glycation
end
products
insulin
resistance
endothelial
dysfunction
tissues.
The
above
mechanisms
cause
development
oxidative
stress
(OS)
reactions
mitochondrial
dysfunction,
which
turn
contribute
DN.
Modern
antioxidant
therapies
involve
various
phytochemicals
(food
antioxidants,
resveratrol,
curcumin,
alpha-lipoic
acid
preparations,
etc.),
are
widely
used
only
diabetes
but
also
other
systemic
diseases.
It
been
suggested
therapeutic
approaches
target
source
reactive
oxygen
species
may
certain
advantages
terms
nephroprotection
from
OS.
review
describes
significance
studies
OS
biomarkers
pathogenesis
analyzes
reducing
intensity
prevention
Cellular and Molecular Life Sciences,
Journal Year:
2024,
Volume and Issue:
81(1)
Published: Jan. 11, 2024
Abstract
The
functional
and
structural
changes
in
the
proximal
tubule
play
an
important
role
occurrence
development
of
diabetic
kidney
disease
(DKD).
Diabetes-induced
metabolic
changes,
including
lipid
metabolism
reprogramming,
are
reported
to
lead
state
tubular
epithelial
cells
(TECs),
among
all
disturbances
metabolism,
mitochondria
serve
as
central
regulators.
Mitochondrial
dysfunction,
accompanied
by
increased
production
mitochondrial
reactive
oxygen
species
(mtROS),
is
considered
one
primary
factors
causing
injury.
Most
studies
have
discussed
how
altered
flux
drives
oxidative
stress
during
DKD.
In
present
study,
we
focused
on
targeting
damage
upstream
factor
abnormalities
under
conditions
TECs.
Using
SS31,
a
tetrapeptide
that
protects
cristae
structure,
demonstrated
contributes
TEC
injury
peroxidation
caused
accumulation.
Mitochondria
protected
using
SS31
significantly
reversed
decreased
expression
key
enzymes
regulators
fatty
acid
oxidation
(FAO),
but
had
no
obvious
effect
major
glucose
rate-limiting
enzymes.
facilitated
renal
Sphingosine-1-phosphate
(S1P)
deposition
limited
elevated
Acer1,
S1pr1
SPHK1
activity,
Spns2
expression.
These
data
suggest
unbalanced
droplet
(LD)
formulation,
peroxidation,
impaired
FAO
sphingolipid
homeostasis
An
vitro
study
high
drove
cytosolic
phospholipase
A2
(cPLA2),
which,
turn,
was
responsible
for
LD
generation
S1P
accumulation,
HK-2
cells.
A
mitochondria-targeted
antioxidant
inhibited
activation
cPLA2f
isoforms.
Taken
together,
these
findings
identify
mechanistic
links
between
reprogrammed
TECs,
provide
further
evidence
nephroprotective
effects
via
influencing
pathways.
Kidney International,
Journal Year:
2024,
Volume and Issue:
106(1), P. 24 - 34
Published: April 16, 2024
Kidney
epithelial
cells
have
very
high
energy
requirements,
which
are
largely
met
by
fatty
acid
oxidation.
Complex
changes
in
lipid
metabolism
observed
patients
with
kidney
disease.
Defects
oxidation
and
increased
uptake,
especially
the
context
of
hyperlipidemia
proteinuria,
contribute
to
this
excess
build-up
exacerbate
disease
development.
Recent
studies
also
highlighted
role
de
novo
lipogenesis
fibrosis.
The
defect
causes
starvation.
Increased
synthesis,
lower
can
cause
toxic
build-up,
reactive
oxygen
species
generation,
mitochondrial
damage.
A
better
understanding
these
metabolic
processes
may
open
new
treatment
avenues
for
diseases
targeting
metabolism.
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(6)
Published: June 24, 2024
Abstract
Diabetic
kidney
disease,
known
as
a
glomerular
arises
from
metabolic
disorder
impairing
renal
cell
function.
Mitochondria,
crucial
organelles,
play
key
role
in
substance
metabolism
via
oxidative
phosphorylation
to
generate
ATP.
Cells
undergo
reprogramming
compensatory
mechanism
fulfill
energy
needs
for
survival
and
growth,
attracting
scholarly
attention
recent
years.
Studies
indicate
that
mitochondrial
significantly
influences
the
pathophysiological
progression
of
DKD.
Alterations
lead
abnormal
expression
signaling
molecules
activation
pathways,
inducing
stress-related
cellular
damage,
inflammatory
responses,
apoptosis,
autophagy
irregularities,
culminating
fibrosis
insufficiency.
This
review
delves
into
impact
on
DKD
pathogenesis,
emphasizing
regulation
regulators
downstream
pathways.
Therapeutic
interventions
targeting
can
potentially
delay
progression.
The
findings
underscore
importance
focusing
develop
safer
more
effective
therapeutic
approaches.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(1), P. 137 - 137
Published: Jan. 22, 2024
Kidney
fibrosis,
diffused
into
the
interstitium,
vessels,
and
glomerulus,
is
main
pathologic
feature
associated
with
loss
of
renal
function
chronic
kidney
disease
(CKD).
Fibrosis
may
be
triggered
in
diseases
by
different
genetic
molecular
insults.
However,
several
studies
have
shown
that
fibrosis
can
linked
to
oxidative
stress
mitochondrial
dysfunction
CKD.
In
this
review,
we
will
focus
on
three
pathways
link
namely:
(i)
hyperglycemia
energy
imbalance,
(ii)
mineralocorticoid
signaling
pathway,
(iii)
hypoxia-inducible
factor
(HIF)
pathway.
We
selected
these
because
they
are
targeted
available
medications
capable
reducing
such
as
sodium-glucose
cotransporter-2
(SGLT2)
inhibitors,
non-steroidal
receptor
antagonists
(MRAs),
HIF-1alpha-prolyl
hydroxylase
inhibitors.
These
drugs
a
reduction
reduced
collagen
deposition
across
CKD
subtypes.
there
still
long
winding
road
clear
understanding
anti-fibrotic
effects
compounds
humans,
due
inherent
practical
ethical
difficulties
obtaining
sequential
biopsies
lack
specific
biomarkers
measurable
easily
accessible
matrices
like
urine.
narrative
describe
pathways,
their
interconnections,
activity
fibrosis.
Cells,
Journal Year:
2023,
Volume and Issue:
12(12), P. 1584 - 1584
Published: June 8, 2023
Kidney
disease
is
a
significant
health
problem
worldwide,
affecting
an
estimated
10%
of
the
global
population.
encompasses
diverse
group
disorders
that
vary
in
their
underlying
pathophysiology,
clinical
presentation,
and
outcomes.
These
include
acute
kidney
injury
(AKI),
chronic
(CKD),
glomerulonephritis,
nephrotic
syndrome,
polycystic
disease,
diabetic
many
others.
Despite
distinct
etiologies,
these
share
common
feature
immune
system
dysregulation
metabolic
disturbances.
The
pathways
are
intimately
connected
interact
to
modulate
pathogenesis
diseases.
responses
diseases
includes
complex
interplay
between
various
cell
types,
including
resident
infiltrating
cells,
cytokines,
chemokines,
complement
factors.
factors
can
trigger
perpetuate
inflammation,
causing
renal
tissue
progressive
fibrosis.
In
addition,
play
critical
roles
diseases,
glucose
lipid
metabolism,
oxidative
stress,
mitochondrial
dysfunction,
altered
nutrient
sensing.
Dysregulation
contributes
progression
by
inducing
tubular
injury,
apoptosis,
Recent
studies
have
provided
insights
into
intricate
revealing
novel
therapeutic
targets
for
prevention
treatment
Potential
strategies
modulating
through
targeting
key
or
inhibiting
pro-inflammatory
signaling
pathways,
improving
function,
nutrient-sensing
such
as
mTOR,
AMPK,
SIRT1.
This
review
highlights
importance
potential
implications
pathways.
Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
11
Published: Aug. 11, 2023
Diabetic
kidney
disease
(DKD)
is
the
most
important
microvascular
complication
of
diabetes
and
leading
cause
end-stage
renal
(ESRD)
worldwide.
The
Janus
kinase/signal
transducer
activator
transcription
(JAK/STAT)
signaling
pathway,
which
out
balance
in
context
DKD,
acts
through
a
range
metabolism-related
cytokines
hormones.
JAK/STAT
primary
node
progression
DKD.
latest
research
on
helps
determine
role
this
pathway
factors
associated
with
DKD
progression.
These
include
renin–angiotensin
system
(RAS),
fibrosis,
immunity,
inflammation,
aging,
autophagy,
EMT.
This
review
epitomizes
progress
understanding
complicated
explanation
etiologies
discusses
whether
it
can
be
potential
target
for
treating
It
further
summarizes
inhibitors,
natural
products,
other
drugs
that
are
promising
how
these
inhibitors
alleviate
to
explore
possible
will
contribute
formulating
effective
treatment
strategies
near
future.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(7), P. 1732 - 1732
Published: April 1, 2023
The
kidney
is
a
crucial
organ
that
eliminates
metabolic
waste
and
reabsorbs
nutritious
elements.
It
also
participates
in
the
regulation
of
blood
pressure,
maintenance
electrolyte
balance
pH
homeostasis,
as
well
erythropoiesis
vitamin
D
maturation.
Due
to
such
heavy
workload,
an
energy-demanding
constantly
exposed
endogenous
exogenous
insults,
leading
development
either
acute
injury
(AKI)
or
chronic
disease
(CKD).
Nevertheless,
there
are
no
therapeutic
managements
treat
AKI
CKD
effectively.
Therefore,
novel
approaches
for
fighting
urgently
needed.
This
review
article
discusses
role
α-lipoic
acid
(ALA)
preventing
treating
diseases.
We
focus
on
various
animal
models
by
which
underlying
renoprotective
mechanisms
ALA
have
been
unraveled.
covered
include
diabetic
nephropathy,
sepsis-induced
injury,
renal
ischemic
unilateral
ureteral
obstruction,
injuries
induced
folic
metals
cisplatin,
cadmium,
iron.
highlight
common
ALA’s
protective
actions
decreasing
oxidative
damage,
increasing
antioxidant
capacities,
counteracting
inflammation,
mitigating
fibrosis,
attenuating
nephron
cell
death.
these
achieves
its
biological
function
alleviating
improving
function.
we
point
out
more
comprehensive,
preclinical,
clinical
studies
will
be
needed
make
better
agent
targeting
disorders.